Letter: Keep drug sellers well out of it

Last updated 12:00 11/07/2012

Relevant offers

Letters to the Editor

Remember to keep your distance Think hard before you judge people Context needed over Sydney siege Police shouldn't have apologised Airport costs hammer ratepayers Argument to merge doesn't stack up Praise and support for former MP's actions Social housing a poor result Speed signs add to confusion Top-down model doomed to fail

OPINION: Kevin Sheehy, representing New Zealand pharmaceutical companies, claims Pharmac's tightly controlled list of subsidised medicines prevents general use of new, beneficial but unlisted medicines (Opinion, July 5). He implies that, if patients had to pay more for their prescription items (a dubious move in itself), more medicines could be subsidised.

The problem with that is that it tackles only his industry's interests: the provision of as many medicines as possible for profit.

Though not disputing that greater medicine choice and subsidised availability have advantages for prescribers and patients, there might be better ways to spend any spare funds within the capped health budget that are more likely to enable us "to live productive and fulfilling lives', as Sheehy describes.

He wills us to avoid compromising patients' health outcomes. His industry's submissions should be considered. But I know I'd prefer medical professionals engaged by the Health Ministry, together with Pharmac, to make the decisions on the nation's optimal level of medicines expenditure and our best bag of subsidised medicines. I prefer this infinitely more than allowing executives from the international medicines industry to have any control over these decisions.

GAVIN SCOTT

Pinehaven

Ad Feedback

- The Dominion Post

Special offers

Featured Promotions

Sponsored Content